Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 281
Filter
1.
Arq. bras. neurocir ; 41(1): 43-50, 07/03/2022.
Article in English | LILACS | ID: biblio-1362077

ABSTRACT

Introduction Intracranial aneurysm (IA) is a major healthcare concern. The use of statin to reduce serum cholesterol has shown evidence to reduce cardiovascular risk in various diseases, but the impact on IA has not been described. This study aims to determine whether statin use, and serum cholesterol levels interfere with outcomes after IA event. Methods A cohort of patients with IA was analyzed. Patients social and demographics data were collected.Modified Rankin scale (mRS) score after 6months of follow-up was the endpoint. The data regarding statins use, presence or not of atherosclerotic plaque in radiological images and serum cholesterol of 35 patients were included in our study. Linear regression models were used to determine the influence of those 6 variables in the clinical outcome. Results The prevalence of atherosclerotic plaque, high cholesterol and use of statins was 34.3%, 48.5%, and 14.2%, respectively. Statins and serum cholesterol did not impact the overall outcome,measured by mRS after 6 months (p>0.05), but did show different tendencies when separated by IA rupture status. Serum cholesterol shows na important association with rupture of aneurysm (p»0.0382). High cholesterol and use of statins show a tendency for worse outcome with ruptured aneurysm, and the opposite is true for unruptured aneurysm. The presence of atherosclerotic plaques was not related with worse outcomes. Conclusions Multiple and opposite mechanisms might be involved in the pathophysiology of IA. Ruptured aneurysms are associated with higher levels of serum cholesterol. Serum cholesterol and statins use were not correlated with worse outcomes, but further studies are important to clarify these relationships.


Introdução Aneurisma intracranial (AI) é uma grande preocupação para a saúde. Evidências apontam que o uso de estatina para reduzir o colesterol sérico diminui o risco cardiovascular em diversas doenças, mas o impacto em AI ainda não foi descrito. Este estudo almeja determinar se o uso de estatina e o nível sérico de colesterol interferem no desfecho clínico após a ocorrência de AIs. Métodos Uma coorte de pacientes com AI foi analisada. Os dados sociodemográficos dos pacientes foram coletados. Ao final de 6 meses de acompanhamento, aplicou-se a escala modificada de Rankin (mRS). Os dados sobre uso de estatina, existência de placa aterosclerótica em imagens radiológicas, e colesterol sérico de 35 pacientes foram incluídos no estudo. Modelos de regressão linear foram usados para determinar a influência dessas 6 variáveis nos desfechos clínicos. Resultados A prevalência de placa aterosclerótica, colesterol elevado, e uso de estatina foram respectivamente 34,3%, 48,5% e 14,2%. Estatina e colesterol sérico não impactaram nos desfechos medidos pela mRS em 6 meses (p > 0,05), mas mostraram diferentes tendências quando separados pelo estado de ruptura do AI. Colesterol sérico apresenta uma importante associação com ruptura de aneurisma (p » 0,0382). Colesterol elevado e uso de estatinas representam uma tendência a piores desfechos para aneurismas rompidos, e o oposto é verdade para os não rompidos. A presença de placa aterosclerótica não está relacionada com piores resultados. Conclusões Mecanismos múltiplos e opostos podem estar envolvidos na patofisio logia do AI. Aneurismas rompidos estão associados com maiores níveis de colesterol sérico. Colesterol sérico e estatinas não foram correlacionados com piores desfechos, mas mais estudos são importantes para clarificar a relação entre esses fatores


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Intracranial Aneurysm , Cholesterol/analysis , Hydroxymethylglutaryl-CoA Reductase Inhibitors/analysis , Plaque, Atherosclerotic/epidemiology , Linear Models , Cohort Studies , Data Interpretation, Statistical
2.
Arq. bras. med. vet. zootec. (Online) ; 72(4): 1545-1554, July-Aug. 2020. tab
Article in English | LILACS, VETINDEX | ID: biblio-1131469

ABSTRACT

This study aimed to evaluate the effects of different nutritional plans on the productive, physiological and metabolic parameters of F1 ½ Holstein x ½ Zebu cows in different stages of lactation. Sixty lactating cows were allotted to a completely randomized 5 x 3 factorial design with five feed allowances and three lactation periods. The dry matter intake, milk yield and heart rate were reduced by 5.69kg, 2.41kg and 10.36 beats/min (morning) and 10.25 beats/min (afternoon) for each 1% feed restriction, respectively. There was no difference in the concentration of glucose, total protein, albumin, cholesterol and non-esterified fatty acids for cows subjected to different feed allowances, with means of 95.25, 7.98, 2.95, 121.68 and 0.45mg/dL, respectively. Feed restriction of up to 2.50% BW is a cost reduction strategy that does not alter milk yield, regardless of the stage of lactation.(AU)


Objetivou-se avaliar os efeitos de diferentes planos nutricionais sobre as características produtivas, fisiológicas e metabólicas de vacas F1 ½ Holandês x ½ Zebu. Foram utilizadas 60 vacas em lactação, seguindo-se o delineamento inteiramente ao acaso, em esquema fatorial 5 x 3, com cinco níveis de oferta de dieta e três períodos de lactação. À medida que se aumentou 1% na restrição da oferta da dieta, houve redução linear de 5,69kg no consumo de matéria seca pelos animais, 2,41kg na produção de leite, bem como de 10,36bat/min (manhã) e 10,25 bat/min (tarde) na frequência cardíaca dos animais. Não houve diferença para a concentração de glicose, proteínas totais, albumina, colesterol e NEFA com a restrição na oferta da dieta dos animais, sendo a média de 95,25, 7,98, 2,95, 121,68 e 0,45mg/dL, respectivamente. Recomenda-se a restrição de até 2,50% de peso corporal como estratégia de redução dos custos em todos os estágios em lactação, visando não alterar, economicamente, a produção de leite.(AU)


Subject(s)
Animals , Female , Cattle , Lactation , Cholesterol/analysis , Diet Therapy/veterinary , Glucose/analysis , Fatty Acids, Nonesterified , Respiratory Rate
3.
Rev. chil. nutr ; 47(2): 181-189, abr. 2020. tab
Article in English | LILACS | ID: biblio-1115487

ABSTRACT

The objective of this study was to assess the influence of weight gain on the lipid profile of 135 adolescents between 10 - 14 years at baseline and 15 - 19 years at follow-up, enrolled in public schools in Recife, Brazil. The results showed that a BMI z-score correlated with triglycerides (TG) and with high density trigliceride lipopoteine ratio (TG/HDL-c) in males. In females, high z-score correlated with total cholesterol (TC) and low density lipoprotein (LDL-c). In males, for each unit increase in z-score, TG increased by 14.7 mg/dL and the TG/HDL-c ratio increased by 0.4. Among females, TC increased by 9.4 mg/dL, LDL-c increased by 11.6 mg/dL, non-HDL cholesterol increased by 11.8 mg/dL, and HDL-c decreased by 2.3 mg/dL. In males, excessive weight gain was associated with an increase in TG and TG/HDL-c; in females, it was associated with a higher increase in TG/HDL-c and non-HDL cholesterol. However, z-score variation can be a good predictor of lipid profile changes, even in those that are within the normal range.


El objetivo de este estudio fue evaluar la influencia del aumento de peso en el perfil lipídico de 135 adolescentes de edades entre 10 y 14 años de edad al inicio del estudio y de 15 a 19 años en el seguimiento. Los adolescentes pertenecían a escuelas públicas de Recife, Brasil. Los resultados mostraron que el alto puntaje z de indice de masa corporase (IMC) correlacionaba con triglicéridos (TG) y con relación de triglicéridos con lipoproteínas de alta densidad (TG/HDL-c) en los hombres. En las mujeres, puntaje z de IMC se correlacionó con CT y lipoproteína de baja densidad (LDL-c). En los hombres, por cada unidad de aumento en el puntaje z, los TG aumentaron en 14,7 mg/dL y la relación TG / HDL-c aumentó en 0,4; en las mujeres, el CT aumentó en 9,4 mg/dL, el LDL-c aumentó en 11,6 mg/dL, el colesterol no HDL aumentó en 11,8 mg / dL y el HDL-c disminuyó en 2,3 mg/dL. En los hombres, el aumento de peso excesivo se asoció con un aumento de TG y TG/HDL-c; en las mujeres, con un aumento mayor en TG/HDL-c y colesterol no HDL. Sin embargo, la variación z-score puede ser un buen predictor de cambios en el perfil lipídico, incluso en aquellos que se encuentran dentro del rango normal.


Subject(s)
Humans , Male , Female , Child , Adolescent , Weight Gain , Lipids/analysis , Triglycerides/analysis , Brazil , Cardiovascular Diseases/etiology , Body Mass Index , Cholesterol/analysis , Follow-Up Studies , Dyslipidemias/complications , Lipoproteins, HDL/analysis , Lipoproteins, LDL/analysis
4.
Rev. chil. nutr ; 47(1): 6-13, feb. 2020. tab, graf
Article in Spanish | LILACS | ID: biblio-1092738

ABSTRACT

RESUMEN El objetivo de este trabajo fue evaluar el efecto de las diferentes concentraciones de polidextrosa en la prevención de la obesidad y sus comorbilidades, en ratas alimentados con dieta hipercalórica. Se utilizaron ratas machos Wistar, repartidos en 4 grupos: Grupo control (HC) y 3 grupos que recibieron dieta hipercalórica con suplementación del 2%, 4% y 6% de polidextrosa (HC2%P, HC4%P y HC6%P respectivamente). La dieta hipercalórica utilizada fue la del tipo de cafetería para inducir la obesidad. Se midió peso corporal e ingesta de la dieta, se realizaron pruebas de tolerancia a la glucosa y a la insulina. Los animales fueron sometidos a eutanasia para toma de muestra de sangre medidas antropométricas y pesaje de órganos y tejidos. La polidextrosa disminuyó significantemente el peso, la grasa corporal, la glicemia, los triglicéridos, la intolerancia a la glucosa y la resistencia a la insulina, y aumentó los niveles del colesterol HDL. Se concluye que el consumo de poli- dextrosa redujo las complicaciones derivadas de la obesidad en ratas alimentados con dieta hipercalórica, siendo éste un potencial tratamiento para el control de la obesidad, la diabetes tipo II y las enfermedades cardiovasculares.


ABSTRACT The aim of this study was to evaluate the effect of different polydextrose concentrations for the prevention of obesity and its comorbidities in rats fed a high calorie diet. Thirty male Wistar rats were used. Rats were divided into 4 groups: Control group (HC) and 3 groups which received a hypercaloric diet with 2%, 4% and 6% polydextrose supplementation (HC2%P, HC4%P and HC6%P, respectively). The hypercaloric diet used was of the cafeteria type to induce obesity. Body weight and feed intake were verified weekly. Glucose and insulin tolerance tests were performed five days before finalizing the experiment. At the end of the experiment, animals were euthanized for blood collection, anthropometric measurements and tissue weighing. Polydextrose significantly decreased weight, body fat, blood glucose, triglycerides, glucose intolerance and insulin resistance and increased HDL cholesterol levels. The use of polydextrose reduced the complications of obesity in mice fed a hypercaloric diet. In conclusion, polydextrose may be a promising treatment for controlling obesity, diabetes type II and cardiovascular diseases.


Subject(s)
Animals , Male , Rats , Prebiotics/administration & dosage , Glucans/administration & dosage , Obesity/prevention & control , Body Weight , Energy Intake , Cholesterol/analysis , Rats, Wistar , Diet, High-Fat , Food Additives , Glucose Tolerance Test
5.
Rev. chil. nutr ; 47(1): 73-79, feb. 2020. tab
Article in English | LILACS | ID: biblio-1092746

ABSTRACT

The study aimed to associate the consumption of trans and saturated fats with dyslipidemia in overweight and obese adolescents who participated in the Study of Cardiovascular Risks in Adolescents (ERICA) from February 2013 to November 2014. Anthropometry, food consumption data, and the lipidogram of 9,538 overweight Brazilian adolescents from macro-regions and Teresina were used in the study. We found an association between saturated fats and HDL-c in Teresina and in the Northeastern macro-region (p-value= 0.002 and p-value= 0.033, respectively), showing that adolescents in Teresina who consumed less than 10% of saturated fats were 2.04-fold more likely to have desirable HDL-c (OR= 2.04), while northeastern adolescents were 0.625 less likely to have desirable HDL-c (OR= 0.625). In Teresina, there was an association between saturated fat consumption and total cholesterol (p-value= 0.045), showing that adolescents consuming less than 10% of saturated fats had a 0.543- fold lower odds of having desirable total cholesterol levels (OR= 0.543). Lipid profile was not associated with consumption of trans fats, but with the consumption of saturated fats. It is important to monitor the lipid profile of adolescents, especially in the presence of overweight.


El objective fue asociar el consumo de grasas trans y saturadas y dislipidemia en adolescentes con sobrepeso y obesidad que participaron en el Estudio de Riesgos Cardiovasculares en Adolescentes (ERICA), en el período de febrero de 2013 a noviembre de 2014. Se utilizaron datos antropométricos, consumo alimentario y lipidograma de 9.538 adolescentes, residentes en Brasil, macrorregiones y Teresina. En Teresina y Macroregión Nordeste, hubo asociación entre el consumo de grasa saturada y HDL-c (p-valor= 0,002 y p-valor= 0,033), respectivamente, mostrando que, adolescentes teresinenses con consumo menor que 10% la grasa saturada tiene 2,04 veces más probabilidades de tener HDL-c deseables (OR= 2,04); mientras que los nordestinos que consumen menos del 10% de grasa saturada tienen 0,625 veces la probabilidad de tener HDL-c deseables (OR= 0,625). En Teresina, hubo asociación entre el consumo de grasa saturada y colesterol total (p-valor= 0,045), mostrando que adolescentes con consumo menor que 10% de grasa saturada tienen 0,543 veces la probabilidad de tener colesterol total deseable (OR= 0,543). El perfil lipídico no se asoció al consumo de grasa trans, sino al consumo de grasa saturada. Es importante realizar monitorización del perfil lipídico de adolescentes, especialmente en presencia del sobrepeso.


Subject(s)
Humans , Male , Female , Child , Adolescent , Dietary Fats , Eating , Dyslipidemias , Overweight , Fatty Acids , Heart Disease Risk Factors , Brazil , Anthropometry , Cholesterol/analysis , Trans Fatty Acids , Lipids/analysis , Obesity
6.
Rev. chil. nutr ; 47(1): 135-140, feb. 2020. tab, graf
Article in Spanish | LILACS | ID: biblio-1092753

ABSTRACT

El objetivo de esta revisión fue comparar algunas características nutricionales y de calidad de huevos de tinamou, con huevos de gallina y codorniz. Los huevos de tinamou contienen menos extracto etéreo y proteína en yema, y similar cantidad de proteínas en clara que huevos de gallina y codorniz. La clara del huevo de tinamou contiene más hierro (0,5 mg/100g) que huevos de gallina y codorniz (0,1-0,2 mg/100g). El ácido oleico es el principal ácido graso de la yema de huevos de tinamou, al igual que los otros. El contenido de colesterol en yema de huevo de tinamou (21,2 mg/g) es mayor a los rangos descritos en huevos de gallina (10,9-16,3 mg/g) y codorniz (11,1-15,9 mg/g). El huevo de tinamou tiene un aspecto físico distinto a huevos de gallina y codorniz, la cáscara es de color chocolate oscuro, pesa en promedio 35 g, sus dimensiones son de 50 x 36 mm, y tienen una unidad Haugh inferior a lo registrado para huevos de gallina y codorniz. El huevo de tinamou es una alternativa muy nutritiva como alimento, de características nutricionales similares a huevos de gallina y codorniz, a excepción de su mayor contenido de colesterol en yema y hierro en clara.


The objective of this review was to compare the nutritional characteristics and quality of tinamou eggs. Tinamou eggs have less ether extract and protein in the yolk, they also have a similar quantity of protein in the egg white than hen and quail eggs. The egg white of the tinamou egg has more iron (0,5 mg/100g) compared to hen and quail eggs (0,1-0,2 mg/100g). Oleic acid is the main fatty acid in all three types of eggs. On the other hand, the amount of cholesterol in the tinamou yolk (21,2 mg/g) is higher than the amounts described for hen eggs (10,9-16,3 mg/g) and those of quail (11,1-15,9 mg/g). In terms of the physical characteristics, the tinamou eggshell has a chocolate color, weighs an average of 35g, has a length about 50 x 36 mm and has an inferior Haugh unity than hen and quail eggs. The tinamou egg represents a high nutritive alternative with similar nutritional characteristics compared to hen and quail eggs, with the exception of cholesterol in the yolk and iron in the egg white.


Subject(s)
Animals , Food Quality , Palaeognathae , Eggs , Nutritive Value , Chile , Cholesterol/analysis , Oleic Acid/analysis , Fatty Acids/analysis , Iron/analysis
7.
Einstein (Säo Paulo) ; 18: eAO4876, 2020. tab, graf
Article in English | LILACS | ID: biblio-1039734

ABSTRACT

ABSTRACT Objective To investigate the effects of sericin extracted from silkworm Bombyx mori cocoon on morphophysiological parameters in mice with obesity induced by high-fat diet. Methods Male C57Bl6 mice aged 9 weeks were allocated to one of two groups - Control and Obese, and fed a standard or high-fat diet for 10 weeks, respectively. Mice were then further subdivided into four groups with seven mice each, as follows: Control, Control-Sericin, Obese, and Obese-Sericin. The standard or high fat diet was given for 4 more weeks; sericin (1,000mg/kg body weight) was given orally to mice in the Control-Sericin and Obese-Sericin Groups during this period. Weight gain, food intake, fecal weight, fecal lipid content, gut motility and glucose tolerance were monitored. At the end of experimental period, plasma was collected for biochemical analysis. Samples of white adipose tissue, liver and jejunum were collected and processed for light microscopy analysis; liver fragments were used for lipid content determination. Results Obese mice experienced significantly greater weight gain and fat accumulation and had higher total cholesterol and glucose levels compared to controls. Retroperitoneal and periepididymal adipocyte hypertrophy, development of hepatic steatosis, increased cholesterol and triglyceride levels and morphometric changes in the jejunal wall were observed. Conclusion Physiological changes induced by obesity were not fully reverted by sericin; however, sericin treatment restored jejunal morphometry and increased lipid excretion in feces in obese mice, suggesting potential anti-obesity effects.


RESUMO Objetivo Investigar os efeitos da sericina extraída de casulos de Bombyx mori na morfofisiologia de camundongos com obesidade induzida por dieta hiperlipídica. Métodos Camundongos machos C57Bl6, com 9 semanas de idade, foram distribuídos em Grupos Controle e Obeso, que receberam ração padrão para roedores ou dieta hiperlipídica por 10 semanas, respectivamente. Posteriormente, os animais foram redistribuídos em quatro grupos, com sete animais cada: Controle, Controle-Sericina, Obeso e Obeso-Sericina. Os animais permaneceram recebendo ração padrão ou hiperlipídica por 4 semanas, período no qual a sericina foi administrada oralmente na dose de 1.000mg/kg de massa corporal aos Grupos Controle-Sericina e Obeso-Sericina. Parâmetros fisiológicos, como ganho de peso, consumo alimentar, peso das fezes em análise de lipídios fecais, motilidade intestinal e tolerância à glicose foram monitorados. Ao término do experimento, o plasma foi coletado para dosagens bioquímicas e fragmentos de tecido adiposo branco; fígado e jejuno foram processados para análises histológicas, e amostras hepáticas foram usadas para determinação lipídica. Resultados Camundongos obesos apresentaram ganho de peso e acúmulo de gordura significativamente maior que os controles, aumento do colesterol total e glicemia. Houve hipertrofia dos adipócitos retroperitoneais e periepididimais, instalação de esteatose e aumento do colesterol e triglicerídeos hepáticos, bem como alteração morfométrica da parede jejunal. Conclusão O tratamento com sericina não reverteu todas as alterações fisiológicas promovidas pela obesidade, mas restaurou a morfometria jejunal e aumentou a quantidade de lipídios eliminados nas fezes dos camundongos obesos, apresentando-se como potencial tratamento para a obesidade.


Subject(s)
Animals , Male , Anti-Obesity Agents/therapeutic use , Sericins/therapeutic use , Obesity/drug therapy , Time Factors , Triglycerides/analysis , Body Weight/drug effects , Gastrointestinal Transit/drug effects , Weight Gain/drug effects , Adipose Tissue/pathology , Cholesterol/analysis , Reproducibility of Results , Treatment Outcome , Anti-Obesity Agents/pharmacology , Sericins/pharmacology , Eating/drug effects , Fatty Liver/pathology , Diet, High-Fat/adverse effects , Glucose Tolerance Test , Liver/metabolism , Mice, Inbred C57BL , Mice, Obese , Obesity/etiology , Obesity/physiopathology
8.
Actual. osteol ; 15(3): 214-224, Sept-Dic. 2019. graf, tab
Article in Spanish | LILACS | ID: biblio-1116039

ABSTRACT

En la Argentina, las embarazadas presentan alta prevalencia (80%) de hipovitaminosis D y de sobrepeso u obesidad (27,4%). Ambas condiciones pueden aumentar la morbimortalidad materno-fetal. Bajos niveles de vitamina D se han relacionado con aumento del colesterol total, LDL, triglicéridos (Tg) y descenso de HDL. Objetivo: evaluar los niveles de 25-hidroxivitamina D (25OHD) y su relación con el perfil lipídico en pacientes embarazadas de alto riesgo. Materiales y métodos: estudio de corte transversal entre septiembre de 2016 y abril de 2017. Se excluyeron pacientes que recibieron suplementos de vitamina D, con disfunción tiroidea no compensada, malabsorción, insuficiencia cardíaca, renal o hepática y dislipidemia familiar. Niveles circulantes de 25OHD < 30 ng/ml se consideraron hipovitaminosis. Resultados: se evaluaron 86 embarazadas de 29,3 ± 7,1 años durante la semana 28 ± 6,5. El IMC pregestacional fue 28,3 ± 6,5 kg/m2 y la ganancia de peso 7 ± 4,3 kg. Perfil lipídico: colesterol total 240 ± 54 mg/dl; LDL 156 ± 54 mg/dl; HDL 66 ± 15 mg/dl; Tg 204 ± 80 mg/dl. La media de 25OHD fue de 23,8 ± 9 ng/ml, con una prevalencia de hipovitaminosis D de 77,9 %. Las pacientes con hipovitaminosis D presentaron mayores valores de colesterol total y LDL (p < 0,05), con tendencia no significativa a presentar mayores valores de Tg. Conclusión: en embarazadas de alto riesgo se observó una alta prevalencia de hipovitaminosis D, asociada con mayores concentraciones de colesterol total y LDL. (AU)


In Argentina, pregnant women have a high prevalence (80 %) of hypovitaminosis D and verweight/obesity (27.4%), conditions that can increase maternal-fetal morbidity and mortality. Low levels of 25-hydroxyvitamin D (25OHD) have been linked to an increase in total cholesterol, LDL cholesterol, triglycerides (TG) and a decrease in HDL cholesterol. Objective: to evaluate the levels of vitamin D and its relationship with the lipid profile in high risk pregnant patients. Materials and methods: cross-sectional study between September 2016 and April 2017. Patients who received vitamin D supplements or had non-compensated thyroid dysfunction, malabsorption, heart failure, renal or hepatic failure, or familial dyslipidemia were excluded. Hypovitaminosis D was defined as a circulating level of 25OHD < 30 ng/ml. Results: We assessed 86 women of 29.3 ± 7.1 years during pregnancy week 28 ± 6.5. Pre-gestational BMI was 28.3 ± 6.5 kg/m2. Their weight gain was 7 ± 4.3 kg. Lipid profile: total cholesterol 240 ± 54 mg/dl; LDL cholesterol 156 ± 54 mg/dl; HDL cholesterol 66 ± 15 mg/dL; TG 204 ± 80 mg/dl. The mean 25OHD level was 23.8 ± 9 ng/ml, with a 77.9 % prevalence of hypovitaminosis D. Patients with hypovitaminosis D had higher values of total cholesterol and LDL cholesterol (p<0.05), and a non-significant trend toward higher triglyceridemia. Conclusion: A high prevalence of hypovitaminosis D, associated with high total and LDL cholesterol was found in high risk pregnant women. (AU)


Subject(s)
Humans , Female , Pregnancy , Adult , Young Adult , Avitaminosis/metabolism , Vitamin D/metabolism , Pregnancy, High-Risk/metabolism , Argentina/epidemiology , Avitaminosis/blood , Avitaminosis/epidemiology , Vitamin D/analysis , Vitamin D/blood , Epidemiologic Studies , Body Mass Index , Cholesterol/analysis , Cholesterol/blood , Indicators of Morbidity and Mortality , Public Health/statistics & numerical data , Cross-Sectional Studies/statistics & numerical data , Diabetes, Gestational/metabolism , Pregnancy, High-Risk/blood , Dyslipidemias/metabolism , Overweight/metabolism , Obstetric Labor, Premature/metabolism , Cholesterol, LDL/analysis , Cholesterol, LDL/blood , Obesity/metabolism
10.
Hig. aliment ; 33(288/289): 1115-1118, abr.-maio 2019. tab
Article in Portuguese | LILACS, VETINDEX | ID: biblio-1482110

ABSTRACT

Foram utilizadas amostras de peito de frangos de corte de três linhagens genéticas contendo diferentes graus de estrias brancas aparentes na superfície do músculo. Foram avaliados concentração de colesterol, percentual de gordura e força de cisalhamento (maciez). Com o aumento do grau de severidade da miopatia ocorreu o aumento de gordura e, consequentemente, da maciez da carne de peito de frangos Cobb 500 e Hubbard. Há variação da concentração de colesterol dependendo do acometimento por estrias brancas, a qual precisa ser melhor estudada. As estrias brancas aparentes na superfície do peito estão associadas à maior deposição de gordura na carcaça do frango, o que, consequentemente, pode influenciar a maciez da carne.


Subject(s)
Animals , Meat/analysis , Cholesterol/analysis , Poultry Diseases , Striae Distensae/veterinary , Chickens , Lipids/analysis , Atherosclerosis/veterinary , Muscular Diseases/veterinary
11.
Int. j. morphol ; 36(4): 1350-1355, Dec. 2018. graf
Article in English | LILACS | ID: biblio-975707

ABSTRACT

SUMMARY: We sought to investigate the potential protective effect of Vitamin E supplementation against hepatocyte ultrastructural alterations induced by high fat diet (HFD) in a rat model of pre-diabetes. Therefore, rats were either fed with HFD (model group) or a standard laboratory chow (control group) for 12 weeks before being sacrificed. The protective group fed on a HFD and started the treatment with vitamin E (100 mg/kg/day, i.p) from day 1 until being sacrificed at week 12. The harvested liver tissues were examined using transmission electron microscopy (TEM) and blood samples were assayed for biomarkers of liver injury and prediabetes. TEM images showed that HFD induced profound pathological changes to the hepatocyte ultrastructure as demonstrated by degenerated hepatocytes with damaged cytoplasm that have mitochondrial swelling, dilation of endoplasmic reticulum, blebbing of plasma membranes, and cytoplasmic accumulations of lipid droplets and vacuoles, which were substantially but not completely protected with vitamin E. In addition, HFD significantly (p<0.05) augmented biomarkers of liver injury and pre-diabetes such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), tumor necrosis factor-alpha (TNF-α), malondialdehyde (MDA), total cholesterol (TC), triglycerides (TG), and low density lipoprotein cholesterol (LDL-C), which were significantly (p<0.05) reduced with vitamin E except TNF-α and TC. Furthermore, none of these biomarkers were reduced to the control level by vitamin E. We conclude that vitamin E is a partial protective agent against HFD-induced liver injury and pre-diabetes.


RESUMEN: El objetivo de este estudio fue investigar el posible efecto protector de la administración de suplementos de vitamina E contra las alteraciones ultraestructurales de los hepatocitos inducidas por una dieta rica en grasas (DRG) en un modelo de prediabetes en ratas. Antes de ser sacrificadas las ratas fueron alimentadas con DRG (grupo modelo) o un alimento estándar de laboratorio (grupo control) durante 12 semanas. El grupo protector se alimentó con una DRG y comenzó el tratamiento con vitamina E (100 mg/kg/día, i.p) desde el día 1 hasta sacrificarlo en la semana 12. Los tejidos hepáticos recolectados se examinaron mediante microscopía electrónica de transmisión (MET) y se tomaron muestras de sangre y se analizaron los biomarcadores de daño hepático y prediabetes. Las imágenes de MET mostraron que el DRG indujo cambios patológicos profundos en la ultraestructura de los hepatocitos, como lo demuestran los hepatocitos degenerados con citoplasma dañado e hinchazón mitocondrial, dilatación del retículo endoplasmático, formación de ampollas en las membranas plasmáticas y acumulaciones citoplásmicas de gotas de lípidos y vacuolas, los que fueron sustancialmente protegidas con vitamina E. Además, DRG aumentó significativamente (p <0,05) los biomarcadores de daño hepático y prediabetes como alanina aminotransferasa (ALT), aspartato aminotransferasa (AST), factor de necrosis tumoral alfa (TNF-α), malondialdehído (MDA), colesterol total (CT), triglicéridos (TG) y lipoproteína de colesterol de baja densidad (LDL-C), la cual se redujo significativamente (p <0,05) con vitamina E, excepto TNF-α y CT. Ninguno de estos biomarcadores se redujo al nivel de control por la vitamina E. Concluimos que la vitamina E es un agente protector parcial contra la lesión hepática inducida por DRG y la prediabetes.


Subject(s)
Animals , Rats , Prediabetic State/drug therapy , Vitamin E/administration & dosage , Hepatocytes/drug effects , Diet, High-Fat/adverse effects , Aspartate Aminotransferases/drug effects , Vitamin E/pharmacology , Cholesterol/analysis , Tumor Necrosis Factor-alpha/drug effects , Oxidative Stress/drug effects , Hepatocytes/ultrastructure , Microscopy, Electron, Transmission , Alanine Transaminase/drug effects , Disease Models, Animal , Non-alcoholic Fatty Liver Disease/prevention & control , Liver/drug effects , Malondialdehyde/analysis
12.
Arch. latinoam. nutr ; 68(3): 211-216, sept. 2018. ilus, tab
Article in English | LIVECS, LILACS | ID: biblio-1015922

ABSTRACT

The objective of this study was to evaluate the effect of sweet potato vines as a source of fiber on the plasma parameters in healthy rabbits. For this, 15 rabbits were allocated into five groups, and each group was fed a different diet for a period of 46 days. The diets were as follows: diet without sweet potato vines (0SPV), and experimental diets with 25%, 50%, 75% and 100% of sweet potato vines in replacement of alfalfa hay respectively (25SPV, 50SPV, 75SPV and 100SPV). Triglycerides and VLDL-cholesterol concentrations were approximately 53% lower in rabbits fed the 100SPV than in rabbits fed 0SPV. In addition, aspartate aminotransferase (AST) and total-cholesterol concentrations were lower approximately 40% and 14%, respectively, in rabbits fed the 100SPV than in rabbits fed 0SPV. No significant differences were found among HDL-cholesterol, glucose, proteins, albumin and alanine aminotransferase (ALT) concentrations of the five groups. These results demonstrate that the consumption of sweet potato vines reduces the triglycerides, VLDLcholesterol and total cholesterol while maintains HDL-cholesterol levels. Therefore, sweet potato vines consumption may be another option to prevent coronary heart diseases in rabbits(AU)


O objetivo deste estudo foi avaliar com base no plasma sanguíneo o efeito do baraço de batata-doce como fonte de fibra. Para tal, dividiuse 15 coelhos em cinco grupos, onde cada grupo foi alimentado com uma dieta diferente por 46 dias. As dietas foram: sem baraço de batata-doce (0SPV), e dietas experimentais com 25%, 50%, 75% e 100% de baraço de batata-doce em substituição ao feno de alfafa, respectivamente (25SPV, 50SPV, 75SPV e 100SPV). As concentrações de triglicérides e VLDL-colesterol foram aproximadamente 53% menores em coelhos alimentados com a dieta 100SPV do que os coelhos alimentados com 0SPV. Além disso, as concentrações de aspartato aminotransferase (AST) e colesterol total foram inferiores em aproximadamente 40% e 14%, respectivamente, nos coelhos alimentados com 100 SPV do que em coelhos alimentados com 0SPV. Não foram encontradas diferenças significativas entre as concentrações colesterol-HDL, glicose, proteínas, albumina e alanina aminotransferase (ALT) dos cinco grupos. Estes resultados demonstram que o consumo de baraço de batata-doce reduz os triglicerídeos, colesterol VLDL e colesterol total, enquanto mantém os níveis de colesterol HDL. Portanto, o baraço de batata-doce pode ser uma opção viável para prevenir doenças coronarianas(AU)


Subject(s)
Animals , Rabbits , Dietary Fiber/administration & dosage , Cholesterol/analysis , Ipomoea batatas , Fatty Acids/analysis , Medicago sativa , Diet, Food, and Nutrition
13.
Cienc. Trab ; 20(61): 1-6, abr. 2018. tab
Article in Spanish | LILACS | ID: biblio-952557

ABSTRACT

INTRODUCCIÓN: El riesgo cardiovascular es una de las principales pre ocupaciones de los servicios de salud laboral. MATERIAL Y MÉTODOS: Se realiza un estudio retrospectivo y transversal en 2944 varones conductores profesionales (487 taxistas, 908 con ductores de autobús y 1549 conductores de camión) y se valoran diferentes variables relacionadas con riesgo cardiovascular. RESULTADOS: El 27,4% de los conductores son obesos, el 25% hiper tensos, un 48% presentan valores elevados de colesterol y un 29,5% triglicéridos altos, mientras la hiperglucemia aparece en el 6,5%. Un 15,8% cumplen los criterios de síndrome metabólico, un 2,6% presentan valores elevados en la escala REGICOR y un 7,9% en la escala SCORE. El riesgo elevado de padecer diabetes tipo 2 con la escala Findrisk aparece en el 13% de los conductores. CONCLUSIONES: Globalmente, el colectivo de taxistas es el que presenta peores resultados en todas las variables relacionadas con riesgo cardiovascular.


INTRODUCTION: Cardiovascular risk is one of the main concerns of occupational health services. MATERIAL AND METHODS: A retrospective and cross-sectional study was conducted in 2944 professional male drivers (487 taxi drivers, 908 bus drivers and 1549 truck drivers) and different variables related to cardiovascular risk were assessed. RESULTS: 27.4% of the drivers are obese, 25% hypertensive, 48% have high cholesterol and 29.5% high triglycerides, while hyperglycemia appears in 6.5%. 15.8% met the metabolic syndrome criteria, 2.6% presented high values on the REGICOR scale and 7.9% on the SCORE scale. The high risk of type 2 diabetes with the Findrisk scale appears in 13% of drivers. CONCLUSIONS: Globally the group of taxi drivers is the one that pres ents worse results in all the variables related to cardiovascular risk.


Subject(s)
Humans , Male , Adult , Automobile Driving , Cardiovascular Diseases/etiology , Risk Assessment/methods , Spain , Transportation , Triglycerides/analysis , Cardiovascular Diseases/epidemiology , Cholesterol/analysis , Cross-Sectional Studies , Multivariate Analysis , Retrospective Studies , Risk Factors , Diabetes Mellitus, Type 2 , Healthy Lifestyle , Hyperglycemia , Hypertension/epidemiology , Obesity/epidemiology
14.
São Paulo; s.n; s.n; 2018. 162 p. tab, graf.
Thesis in English | LILACS | ID: biblio-911601

ABSTRACT

Aldeídos de colesterol (Secosterol A e Secosterol B) têm sido detectados em amostras de cérebro humano e investigados em modelos de doenças neurodegenerativas como possíveis marcadores e intermediários do processo patológico. Estes oxisteróis constituem uma classe de eletrófilos derivados de lipídeos que podem modificar e induzir agregação de proteínas. A esclerose lateral amiotrófica (ELA) é um distúrbio neurodegenerativo associado ao acúmulo de agregados imunorreativos de superóxido dismutase (Cu, Zn-SOD, SOD1). O objetivo deste trabalho foi avaliar a presença de aldeídos de colesterol em ratos modelo ELA e sua capacidade de induzir a formação de agregados de SOD1 in vitro. Aldeídos de colesterol foram analisados no plasma, medula espinhal e córtex motor de ratos ELA. Uma quantidade elevada de Secosterol B foi detectada no córtex motor desses ratos em comparação com animais controle. Adicionalmente, os experimentos in vitro mostraram que Secosterol B e Secosterol A induziram a agregação da SOD1 em uma forma amiloidogênica que se liga à tioflavina T. Esta agregação não foi observada com o colesterol e os seus hidroperóxidos. Usando aldeídos de colesterol marcados com grupo alquinil e um ensaio de click chemistry, foi observado que os agregados de SOD1 estão ligados covalentemente aos aldeídos. A modificação covalente da proteína foi confirmada por análise de MALDI-TOF, que mostrou a adição de até cinco moléculas de aldeídos de colesterol à proteína por base de Schiff. Curiosamente, a análise comparativa com outros eletrófilos derivados de lipídeos (e.g. HHE e HNE) demonstrou que a agregação de SOD1 aumentou proporcionalmente à hidrofobicidade dos aldeídos, observando-se a maioragregação com aldeídos de colesterol. Os sítios de modificação da SOD1 foram caracterizados por nanoLC-MS/MS após digestão da proteína com tripsina, onde foram identificadas lisinas como o principal aminoácido modificado. Em geral, nossos dados mostram que a oxidação do colesterol que leva à produção de aldeídos de colesterol é aumentada no cérebro de ratos ELA e que os aldeídos altamente hidrofóbicos derivados de colesterol podem promover eficientemente modificação e agregação de SOD1


Secosterol aldehydes (Secosterol B and Secosterol A) have been detected in human brain samples and investigated in models of neurodegenerative diseases as possible markers and intermediates of the pathological process. These oxysterols constitute a class of lipid-derived electrophiles that can modify and induce aggregation of proteins. Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder associated with the accumulation of immunoreactive aggregates of superoxide dismutase (Cu, Zn-SOD, SOD1). The objective of this work is to evaluate the presence of secosterol aldehydes in ALS rats and their ability to induce formation of SOD1 aggregates in vitro. Secosterol aldehydes were analyzed in plasma, spinal cord and motor cortex of ALS rats. A higher amount of Secosterol B was detected in the motor cortex of these rats compared to control animals. In addition, in vitro experiments have shown that Secosterol B and Secosterol A induce aggregation of SOD1 into an amyloidogenic form that binds to thioflavin T. This aggregation was not apparent in incubations with cholesterol and its hydroperoxides. Using alkynyl-labeled secosterol aldehydes and a click chemistry assay, it was found that the SOD1 aggregates are covalently linked to the aldehydes. Covalent modification of the protein was confirmed by MALDI-TOF analysis, which showed the addition of up to five molecules of secosterol aldehydes to the protein by Schiff base formation. Interestingly, the comparative analysis with other lipid-derived electrophiles (e.g. HHE and HNE) demonstrated that the aggregation of SOD1 increased according to the hydrophobicity of the aldehydes. Compared to the other electrophiles, a higher SOD1 aggregation was observed with secosterol aldehydes. SOD1 modification sites were characterized by nanoLC-MS/MS afterprotein digestion with trypsin, revealing lysine as the major amino acid modified in these experiments. Collectively, our data show that cholesterol oxidation leads to the production of secosterol aldehydes, which are increased in the brain of ALS rats, and that these highly hydrophobic aldehydes can efficiently promote the modification and aggregation of SOD1


Subject(s)
Cholesterol/analysis , Aldehydes/analysis , Amyotrophic Lateral Sclerosis/pathology , Neurodegenerative Diseases/classification , Superoxide Dismutase-1/pharmacology
16.
Rev. méd. Chile ; 145(9): 1099-1105, set. 2017. tab, graf
Article in Spanish | LILACS | ID: biblio-902593

ABSTRACT

Background: It is known that some nutrients play an important role in the development of cholelithiasis. Cholesterol is carried by micelles and vesicles in the bile. During the first stage of gallstone formation, cholesterol crystals derive from thermodynamically unstable vesicles. Aim: To determine the effect of a high fat diet on blood lipids and bile composition, and its implication in the formation of gallstones. Material and Methods: Two groups of 15 BALB/c mice each, coming from the same litter, were treated with a control or with a high-fat diet (64% fat and 0.14% cholesterol). After two months, the animals were sacrificed, blood and bile samples were obtained. Serum glucose and the corresponding lipid profiles were measured. In bile samples, cholesterol and phospholipid levels were analyzed, and cholesterol transporters (vesicles and micelles) were separated by gel filtration chromatography. Results: Treated animals showed an 87% increase in serum total cholesterol (p < 0.01), a 97% increase in HDL-cholesterol (p < 0.05) and a 140% increase in LDL-cholesterol (p < 0.05). No changes in serum triglycerides or glucose were observed. In bile, a 13% increase in biliary cholesterol (p < 0.05) was observed but no change in biliary phospholipids. Also, an increase in biliary vesicular transporters and an increase of cholesterol/phospholipid ratio in vesicular transporters were observed. Conclusions: A high fat diet may contribute to the formation of gallstones in our experimental model.


Subject(s)
Animals , Male , Dietary Fats/metabolism , Gallstones/etiology , Gallstones/metabolism , Cholesterol/metabolism , Diet, High-Fat/adverse effects , Phospholipids/metabolism , Bile/chemistry , Biological Transport , Dietary Fats/analysis , Cholesterol/analysis , Prospective Studies , Treatment Outcome , Models, Animal , Gallbladder/metabolism , Mice, Inbred BALB C
18.
Braz. j. med. biol. res ; 50(11): e6389, 2017. tab, graf
Article in English | LILACS | ID: biblio-888946

ABSTRACT

The objective of this study was to observe the infection of human cytomegalovirus (HCMV) to human umbilical vein endothelial cells, and its effect on the expression of single-stranded DNA-binding protein (SSBP1) and on lipid metabolism in endothelial cells. We screened the differential expression of mRNAs after HCMV infection by suppression subtractive hybridization and the expression levels of SSBP1 mRNA and protein after HCMV infection by real-time PCR and western blot. After verification of successful infection by indirect immunofluorescent staining and RT-PCR, we found a differential expression of lipid metabolism-related genes including LDLR, SCARB, CETP, HMGCR, ApoB and LPL induced by HCMV infection. The expression levels of SSBP1 mRNA and protein after HCMV infection were significantly down-regulated. Furthermore, we found that upregulation of SSBP1 inhibited the expression of atherosclerosis-associated LDLR, SCARB, HMGCR, CETP as well as the accumulation of lipids in the cells. The results showed that the inhibition of SSBP1 by HCMV infection promotes lipid accumulation in the cells.


Subject(s)
Humans , Cytomegalovirus Infections/metabolism , DNA-Binding Proteins/metabolism , Human Umbilical Vein Endothelial Cells/metabolism , Human Umbilical Vein Endothelial Cells/virology , Lipid Metabolism/physiology , Mitochondrial Proteins/metabolism , Atherosclerosis/metabolism , Atherosclerosis/virology , Cholesterol Ester Transfer Proteins/metabolism , Cholesterol/analysis , DNA-Binding Proteins/genetics , Down-Regulation , Hydroxymethylglutaryl CoA Reductases/metabolism , Lipid Metabolism/genetics , Mitochondrial Proteins/genetics , Receptors, LDL/metabolism , Scavenger Receptors, Class B/metabolism , Time Factors
19.
Femina ; 44(4): 265-269, dez. 30, 2016. tab
Article in Portuguese | LILACS | ID: biblio-1050873

ABSTRACT

Atualmente é crescente o número de mulheres atingidas por doenças como Hipertensão Arterial Sistêmica (HAS), Diabetes, Osteoporose e mesmo cânceres, como os de mama e cólon. O médico ginecologista, muitas vezes, é a única referência de saúde destas pacientes. Este artigo visa reunir as recomendações das principais Sociedades Médicas no que diz respeito ao rastreio das comorbidades citadas e os demais cuidados básicos de saúde da mulher. Ele objetiva, portanto, facilitar e ampliar a abordagem prática do ginecologista no consultório para que a mulher seja avaliada de uma maneira mais completa.(AU)


The number of women suffering from diseases such as Systemic Arterial Hypertension, Diabetes, Osteoporosis and breast and colon cancers has grown in the latest decades. The gynecologist is oftenly the only reference in medical care for these women. This article groups the main recommendations from different Medical Societies regarding the tracking of these conditions and other basic aspects on women's health care. It aims to facilitate and broaden the gynecologists' practical approach in evaluating women in a more complete way.(AU)


Subject(s)
Humans , Female , Women's Health , Medical Care , Delivery of Health Care , Diagnostic Tests, Routine , Gynecology/methods , Osteoporosis/diagnostic imaging , Referral and Consultation , Thyroid Diseases/diagnosis , Bacterial Infections/prevention & control , Bacteriuria/diagnosis , Urinary Tract Infections/diagnosis , Vitamin D Deficiency/diagnosis , Virus Diseases/prevention & control , Chlamydia Infections/diagnosis , Cholesterol/analysis , Vaccination , Colonic Neoplasms/diagnosis , Diabetes Mellitus/diagnosis , Monitoring, Physiologic
20.
Ciênc. cuid. saúde ; 15(2): 321-327, Abr.-Jun. 2016. tab
Article in Portuguese | LILACS, BDENF | ID: biblio-974840

ABSTRACT

RESUMO Atualmente as doenças crônicas não transmissíveis são as principais causas de morte no mundo. Consideradas doenças multifatoriais, têm em comum fatores de riscos modificáveis tais como inatividade física, colesterol elevado, excesso de peso, tabagismo, consumo excessivo de bebidas alcoólicas e alimentação não saudável. Com o objetivo de verificar o impacto por um programa de Gerenciamento de Doenças Crônicas, após dois anos de acompanhamento, surgiu esta pesquisa. Trata-se de programa desenvolvido com um grupo de clientes de uma autogestão localizada no estado de São Paulo. É um estudo transversal realizado durante os anos de 2014-2015 com dados de prontuário eletrônico que foram comparados parâmetros clínicos e hábitos de vida de 1.509 indivíduos participantes de um programa de gerenciamento de doenças em dois momentos: na entrada ao programa e após dois anos de participação. Observaram-se resultados satisfatórios na melhora de parâmetros clínicos relacionados aos níveis pressóricos e à dosagem de glicemia em jejum, assim como diminuição do sedentarismo em indivíduos abaixo dos 60 anos.


RESUMEN Actualmente las enfermedades crónicas no transmisibles son las principales causas de muerte en todo el mundo. Consideradas enfermedades multifactoriales, tienen en común factores de riesgo modificables, tales como inactividad física, colesterol alto, sobrepeso, tabaco, exceso de alcohol y alimentación poco sana. Con el objetivo de averiguar el impacto por un programa de Gestión de Enfermedades Crónicas, tras dos años de acompañamiento, se hizo esta investigación. Se trata de un programa desarrollado con un grupo de clientes de una autogestión ubicada en el estado de São Paulo, Brasil. Es un estudio transversal realizado durante los años de 2014-2015 con datos de registros médicos electrónicos, comparándose los parámetros clínicos y hábitos de vida de 1.509 personas que participan en un programa de gestión de enfermedades en dos ocasiones: cuando entran en el programa y después de dos años de participación. Se observaron resultados satisfactorios en la mejora de los parámetros clínicos relacionados con los niveles de presión arterial y a la dosificación de glucemia en ayunas, así como la disminución de la inactividad física en personas con edad abajo de 60 años.


ABSTRACT Currently, non-transmissible chronic diseases are leading causes of death worldwide. Considered as multifactorial diseases, they have common modifiable risk factors such as physical inactivity, high cholesterol, overweight, smoking, excessive alcohol consumption, and unhealthy diets. Aiming at verifying the impact of theChronic Disease Management program, this study arose after two years of follow-up. This is a program developed with a group of customers in a self-management platform in the state of São Paulo. This was a cross-sectional study carried out during 2014 and 2015 with electronic medical record data through the comparison ofthe clinical and lifestyle parameters of 1,509 individuals participating in a disease management program in two moments: at the program'sentry and two years after participation. Satisfactory results in the improvement of clinical parameters related to blood pressure and blood glucose levels in fasting were observed as well as decreased physical inactivity in individuals under 60 years of age.


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Health Programs and Plans/standards , Chronic Disease/nursing , Prepaid Health Plans/standards , Health Promotion/standards , Tobacco Use Disorder/prevention & control , Blood Glucose/analysis , Blood Pressure/drug effects , Aging/drug effects , Alcohol Drinking/adverse effects , Cholesterol/analysis , Cause of Death/trends , Glycemic Index/drug effects , Diabetes Mellitus, Type 2/nursing , Diet/statistics & numerical data , Overweight/metabolism , Electronic Health Records/statistics & numerical data , Arterial Pressure/drug effects , Noncommunicable Diseases/classification , Hypertension/nursing , Motor Activity/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL